公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1991 | Expression of Growth-Related Genes and Drug-Resistance Genes in HTLV-I-Positive and HTLV-I-Negative Post-Thymic T-Cell Malignancies | Su, I. J.; Chang, I. C.; Cheng, Ann-Lii; 鄭安理 | Annals Oncology | | | |
1993 | Expression of P-Glycoprotein and Glutathione-S-Transferase in Recurrent Lymphoma:The Possible Role of Epstein-Barr Virus, Immunophenotypes, and Other Predisposing Factors | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Journal of Clinical Oncology | | | |
2015 | Expression of the Helicobater pylori CagA protein is closely associated with Helicobater pylori-dependence of early-stage high-grade gastric lymphoma | Kuo, S. H.; Chen, L. T.; Lin, C. W.; Yeh, K. H.; Tsai, H. J.; Tzeng, Y. S.; Wu, M. S.; Hsu, P. N.; Cheng, A. L.; 林中梧; 郭頌鑫; 鄭安理; 葉坤輝; 吳明賢; 許秉寧 | Eur. J. Cancer | | | |
1997 | Factors Associated with the Therapeutic Efficacy of Retinoic Acids on Malignant Lymphomas | CHENG, ANN-LII; CHUANG, SHUANG-EN; LIN, CHIEN-HSING; LUO, YOU-JEN; PU, YEONG-SHIAU; SU, IH-JEN; 鄭安理 | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | | | |
2012 | THE FIRST-TWO LINES OF CHEMOTHERAPY FOR DE NOVO METASTATIC BREAST CANCER: EFFICACY STUDY BETWEEN ANTHRACYCLINES AND NON-ANTHRACYCLINES | Chen, W. -W.; Chang, D. -Y.; Lin, C. -H.; Hsu, C.; Cheng, A. -L.; Lu, Y. -S.; 鄭安理 | Ann. Oncol. | | | |
2012 | FRONT-LINE ANTIBIOTIC THERAPY IN EARLY-STAGE H. PYLORI-POSITIVE GASTRIC DIFFUSE LARGE B-CELL LYMPHOMAS WITH OR WITHOUT MALT FEATURES | Chen, L. -T.; Kuo, S. -H.; Yeh, K. -H.; Wu, M. -S.; Lin, C. -W.; Hsu, P. -N.; Wang, H. -P.; Cheng, A. -L.; 林中梧; 郭頌鑫; 鄭安理; 葉坤輝; 王秀伯; 吳明賢; 許秉寧 | Ann. Oncol. | | | |
2007 | Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells | SHEN, YING-CHUN; CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理 | Gastric Cancer | | | |
2014 | High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma | Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; 鄭安理 | Cancer | | | |
2012 | HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA | Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 鄭安理; 徐志宏 | Ann. Oncol. | | | |
1988 | HTLV-I-Associated Lymphoma/Leukemia As Secondary Maligenancy in Patients with Hematological Neoplasms | 陳耀昌; 王秋華; Su, Ih-Jen; 鄭安理; Chou, Min-Ji; Essex, Myron; 楊照雄; 陳宜君; Wang, Chiu-Hwa; Chen, Yee-Chun | Experimental Hematology | | | |
2005 | Identification and Characterization of a Novel Gene Saf Transcribed from the Opposite Strand of Fas | YAN, MING-DE; LAI, GI-MING; CHENG, ANN- LII; LIN, YA-WEN; CHUANG, SHUANG-EN; 鄭安理 | HUMAN MOLECULAR GENETICS | | | |
2009 | Impact of Lung and Lymph Node Metastasis on Efficacy and Safety Following Treatment with Sorafenib in Patients with Hepatocellular Carcinoma from the Asia-Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2009 | Impact of Prior Surgical Resection with Curative Intent on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Subset Analysis of the Asia-Pacific (Ap) Study | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | Impact of Prior Tace/Tae on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc) from the Asia- Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2002 | Increase of the Resistance of Human Cervical Carcinoma Cells to Cisplatin by Inhibition of the Mek to Erk Signaling Pathway Partly Via Enhancement of Anticancer Drug-Induced Nf Kappa B Activation | CHENG, ANN-LII; 鄭安理 | BIOCHEMICAL PHARMACOLOGY | | | |
2014 | Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2004 | Interleukin-6 Is Responsible for Drug Resistance and Anti-Apoptotic Effects in Prostatic Cancer Cells | PU, YEONG-SHIAU; HOUR, TZYH-CHYUAN; CHUANG, SHUANG-EN; CHENG, ANN-LII; LAI, MING-KUEN; KUO, MIN-LIANG; 鄭安理 | PROSTATE | | | |
2016 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration | Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 鄭安理; 陳邦斌; 徐志宏 | Annals of Oncology | 0 | 1 | |